Next Article in Journal
Computational Modeling to Predict Fatigue Behavior of NiTi Stents: What Do We Need?
Next Article in Special Issue
Keratoprosthesis: A Review of Recent Advances in the Field
Previous Article in Journal
Using Magnetic Nanoparticles for Gene Transfer to Neural Stem Cells: Stem Cell Propagation Method Influences Outcomes
Previous Article in Special Issue
Fibroblastic Transformation of Corneal Keratocytes by Rac Inhibition is Modulated by Extracellular Matrix Structure and Stiffness
Article Menu

Export Article

Open AccessReview
J. Funct. Biomater. 2015, 6(2), 277-298;

Nanomedicine Approaches for Corneal Diseases

Harry S. Truman Memorial Veteran Hospital, Columbia, MO 65201, USA
Department of Ophthalmology Veterinary Medicine & Surgery, Columbia, MO 65211, USA
Mason Eye Institute, University of Missouri-Columbia, Columbia, MO 65211, USA
Singapore Eye Research Institute, 20 College Road, 169856, Singapore
Author to whom correspondence should be addressed.
Academic Editor: Dimitrios Karamichos
Received: 10 February 2015 / Revised: 28 April 2015 / Accepted: 28 April 2015 / Published: 30 April 2015
(This article belongs to the Special Issue Corneal Disease and Biomaterials)
PDF [4008 KB, uploaded 30 April 2015]


Corneal diseases are the third leading cause of blindness globally. Topical nonsteroidal anti-inflammatory drugs (NSAIDs), steroids, antibiotics and tissue transplantation are currently used to treat corneal pathological conditions. However, barrier properties of the ocular surface necessitate high concentration of the drugs applied in the eye repeatedly. This often results in poor efficacy and several side-effects. Nanoparticle-based molecular medicine seeks to overcome these limitations by enhancing the permeability and pharmacological properties of the drugs. The promise of nanomedicine approaches for treating corneal defects and restoring vision without side effects in preclinical animal studies has been demonstrated. Numerous polymeric, metallic and hybrid nanoparticles capable of transporting genes into desired corneal cells to intercept pathologic pathways and processes leading to blindness have been identified. This review provides an overview of corneal diseases, nanovector properties and their applications in drug-delivery and corneal disease management. View Full-Text
Keywords: corneal diseases; infection; scarring; fibrosis; neovascularization; nanoparticles; nanomedicine; nanomaterials; nanodelivery corneal diseases; infection; scarring; fibrosis; neovascularization; nanoparticles; nanomedicine; nanomaterials; nanodelivery

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Chaurasia, S.S.; Lim, R.R.; Lakshminarayanan, R.; Mohan, R.R. Nanomedicine Approaches for Corneal Diseases. J. Funct. Biomater. 2015, 6, 277-298.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
J. Funct. Biomater. EISSN 2079-4983 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top